Cheap Dividend Champions | 20 Stocks With Highest Growth At Low Valuation
Dividend Champions with highest growth at low pricing figures originally published at "long-term-investments.blogspot.com". Many people want to make money by stock trading but most of them fail. I often tell you that you can only make money if you buy stocks at fair prices with attractive financial ratios. To buy stocks at normal prices gives you the possibility to find more investment opportunities at lower risk.
George Soros Quantum Fund Investment Portfolio as of Q3/2012
100 Most Attractive Stocks Bought By Popular Investment Gurus
Investment gurus are asset or fund managers with big amounts of cash under management. They became popular by big returns and spectacular investment strategies. I talk about investors like George Soros and Warren Buffett. They all have one thing in common: The average return beats the market and if they invest, the market follows.
I made a screen of the biggest stock buys from 49 super investors over the recent six month and ranked them in my 100 best guru buy list. They all bought 594 stocks within the past half year.
The top stocks are now Berkshire Hathaway and Google. Berkshire was bought by 16 stock market professionals and Google by 15. Half of the top ten buys came from the technology sector. Investors still love this field because of the high growth potential and strong cash flows. But technology stocks are no big dividend payer. That’s why I did not invest much of my private wealth in technology stocks. That’s a bad strategy because if you want to have growth, the sector is one of the safest bets for the time being.
3 Reasons Why The Stock Market Should Close After The Super Bowl
Last night, the New York Giants defeated the New England Patriots in the highly anticipated Super Bowl. The game was watched by more than 100 million viewers. The day after the Super Bowl should simply be declared a national holiday in the United States. Many stores could hold sales and promotional events to try and generate business leading up to the game and even the day after the event.
Formula Maker Rebounds After FDA Defends Against Infant Death Allegations
Shares of Mead Johnson have been soaring higher today, along with the S&P 500, though for different reasons.
The United States Food & Drug Administration and the Centers for Disease Control announced this weekend that health inspectors have completed their testing on all formula samples collected from Mead Johnson and concluded that the Enfamil formula in question was safe.